Pseudoephedrine Will Be Behind The Counter Across The Country By October
This article was originally published in The Tan Sheet
Executive Summary
Retailers will have to be prepared to enforce monthly gram purchase limits on pseudoephedrine products by mid-April, once meth control provisions of the Patriot Act reauthorization bill go into effect
You may also be interested in...
PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach
Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.
PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach
Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.
Zephrex-D Efficacy Claim Passes NAD Review After Nexafed Firm Objects
NAD says that Westport Pharmaceuticals supported claims for Zephrex-D’s rate of relief and efficacy challenged by Acura Pharmaceuticals, manufacturer of Nexafed, another nonprescription PSE drug formulated to prevent extraction of the ingredient.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: